TABLE 3.
Parameter | No. patients, n (%) | p | OR (95% CI) |
---|---|---|---|
Sex | |||
Female | 27 (31) | 0.612 | 1.286 (0.486–3.403) |
Male | 60 (69) | — | — |
Age ≥30 y at initial diagnosis | 45 (52) | 0.835 | 1.098 (0.456–2.640) |
Overlap syndrome with AIH | 10 (12) | 0.646 | 0.747 (0.214–2.605) |
Immunosuppressant/biological intake | 24 (28) | 0.865 | 1.088 (0408–2.902) |
Inflammatory bowel disease | 69 (79) | 0.005 | 3.560 (1.424–8.896) |
Proton pump inhibitor intake | 23 (26) | 0.660 | 1.258 (0.451–3.505) |
≥2 ERCPs per patient | 81 (93) | 0.928 | 1.080 (0.205–5.691) |
Relevant stenosis | 78 (90) | 0.082 | NA |
Note: Significant results (p < 0.05) are shown in bold type.
Abbreviations: AIH, Autoimmune hepatitis; ERCP, endoscopic retrograde cholangiopancreatography.